The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.
 
Andrew Louis Himelstein
No Relationships to Disclose
 
Rui Qin
Employment - United Health Group (I)
Stock and Other Ownership Interests - United Health Group (I)
 
Paul J. Novotny
No Relationships to Disclose
 
Drew K. Seisler
No Relationships to Disclose
 
James L. Khatcheressian
No Relationships to Disclose
 
John D. Roberts
No Relationships to Disclose
 
Stephen S. Grubbs
Leadership - Blue Cross and Blue Shield of Delaware
 
Tracey O'Connor
No Relationships to Disclose
 
Douglas Weckstein
Research Funding - ACCRU (Inst); Astellas Pharma (Inst); DCFI (Inst)
 
Charles L. Loprinzi
Consulting or Advisory Role - Cubist; Helsinn Therapeutics
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Cubist
 
Charles L. Shapiro
No Relationships to Disclose